randomized [resa]
DOUBLE BLIND [resa]
placebo controlled study [inpr, resa]
effects [qlco]
Raloxifene [orch, phsu]
Hormone replacement therapy [topp]
plasma concentration [qnco]
Endothelin-1 [aapp, bacs]
Levels [qlco]
Endothelium [tisu]
Dependent [qlco]
Vasodilation [phsf]
postmenopausal [tmco]
Women [popg]
Endothelium [tisu]
Thought [menp]
Play [dora]
Genesis [gngm]
Atherosclerosis [dsyn]
Several [qnco]
lines [spco]
Suggest [idcn]
intervention [hlca]
Endothelial [tisu]
function [phsf]
Involvement [ftcn]
Coronary Disease [dsyn]
progression [patf]
cardiovascular events [fndg]
Estrogen [horm, phsu, strd]
Direct [qlco]
effects [qlco]
Blood vessel wall [bpoc]
Endothelium, Vascular [tisu]
Play [dora]
CARDIOVASCULAR [bdsy]
effects [qlco]
Hormone replacement therapy [topp]
Raloxifene [orch, phsu]
Relax [acty]
Coronary Arteries [bpoc]
In Vitro [inpr]
Estrogen receptor [aapp, rcpt]
Dependent [qlco]
Dependent [qlco]
Mechanism [ftcn]
Suggest [idcn]
Selective Estrogen Receptor Modulator [horm, phsu]
effects [qlco]
Endothelial [tisu]
function [phsf]
Study [mnob]
Compared [acty]
effects [qlco]
Hormone replacement therapy [topp]
Raloxifene [orch, phsu]
Products [enty]
Endothelin-1 [aapp, bacs]
Plasma [bdsu]
Endothelium [tisu]
Dependent [qlco]
Vasodilatation [phsf]
postmenopausal [tmco]
Women [popg]
Health [idcn]
postmenopausal [tmco]
Women [popg]
N NOS [aapp, imft]
>90 [qnco]
DOUBLE BLIND [resa]
randomized [resa]
placebo-controlled [resa]
Trial [resa]
Women [popg]
Assigned [ftcn]
Receive [qlco]
Continuous [idcn]
Hormone replacement therapy [topp]
mg% [qnco]
17 beta-Estradiol [horm, phsu, strd]
Combined [qlco]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
Raloxifene [orch, phsu]
mg/d [qnco]
placebo [topp]
months [tmco]
Flow [npop]
mediated [socb]
Endothelium [tisu]
Dependent [qlco]
Vasodilation [phsf]
Brachial Artery [bpoc]
plasma concentration [qnco]
Endothelin [aapp, bacs]
Levels [qlco]
Measured [qlco]
baseline [bodm]
months [tmco]
therapy [ftcn]
baseline [bodm]
break down [qlco]
Products [enty]
10^7/L [qnco]
Mu [inpr]
Mole [neop]
Increased [qnco]
mU/L [qnco]
Mole [neop]
months [tmco]
treatment [ftcn]
Raloxifene [orch, phsu]
baseline [bodm]
Plasma [bdsu]
Endothelin [aapp, bacs]
pg/mL [qnco]
Decreased [qnco]
pg/mL [qnco]
months [tmco]
treatment [ftcn]
Selective Estrogen Receptor Modulator [horm, phsu]
baseline [bodm]
Ratio [qnco]
break down [qlco]
Products [enty]
Endothelin [aapp, bacs]
Increased [qnco]
End [spco]
treatment [ftcn]
Raloxifene [orch, phsu]
postmenopausal [tmco]
Women [popg]
treated [topp]
Hormone replacement therapy [topp]
Plasma [bdsu]
Nitrites [chvs]
Nitrates [chvs]
Endothelin [aapp, bacs]
Levels [qlco]
Ratio [qnco]
Endothelin [aapp, bacs]
Contrast [qlco]
Marker [clna]
Endothelial [tisu]
function [phsf]
placebo [topp]
treated [topp]
Women [popg]
Flow [npop]
mediated [socb]
Endothelium [tisu]
Dependent [qlco]
Vasodilation [phsf]
Brachial Artery [bpoc]
baseline [bodm]
Increased [qnco]
months [tmco]
treatment [ftcn]
Raloxifene [orch, phsu]
Hormone replacement therapy [topp]
Flow [npop]
mediated [socb]
Endothelium [tisu]
Dependent [qlco]
Vasodilation [phsf]
Flow [npop]
mediated [socb]
Vasodilation [phsf]
Observed [ftcn]
participants [popg]
treated [topp]
placebo [topp]
conclude [bodm, orch]
Raloxifene [orch, phsu]
therapy [ftcn]
Hormone replacement therapy [topp]
Endothelial [tisu]
function [phsf]
Flow [npop]
mediated [socb]
Endothelium [tisu]
Dependent [qlco]
Vasodilation [phsf]
Extent [spco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
treatment [ftcn]
Investigation [hlca]
Enhance [acty]
Understanding [menp]
Mechanisms [ftcn]
Raloxifene [orch, phsu]
Vascular function [clna]
Endothelial [tisu]
function [phsf]
Contribute [acty]
reduction [npop]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
